Accordingly, IL-1β is known to increase BC aggressiveness [34] and plays a key role in the initiation of the metastatic process by increasing MMP-9 and VEGFR expression through increased activation of p38-MAPK and MAPK-activated protein kinase 2, leading to endothelial cell migration and tumor progression [35]. This evidence concerns the gene MAPKAPK2 and breast cancer.